Genetically predicted higher CD40L receptor (CD40) levels were associated with a reduced risk of ADHD (IVW odds ratio: 0.931; 95% CI, 0.894-0.970; P = .001), whereas the other 90 circulating inflammatory proteins were not significantly correlated with ADHD after false discovery rate correction. The gene discussed is CD40; the disease is attention deficit-hyperactivity disorder.